Mr. Ramesh Kambariya, CFO; has tendered resignation which is effective from close of business hours of 11th August 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Chemcrux Enterprises met on 6th August 2025 and approved several items: Q1 FY26 unaudited financial results, appointment of KSPS & Co LLP as Secretarial Auditor for 5 years, and a new ESOP 2025 scheme covering 20 lakh stock options for eligible employees. The Board also approved an increase in authorised share capital from Rs 15 crore to Rs 20 crore. Most notably, CFO Mr. Ramesh Kambariya tendered his resignation effective end of business on 11th August 2025, citing personal career goals — no successor has been announced yet. Separately, the Board approved the continuation of Executive Chairman Mr. Girishkumar Shah and MD Mr. Sanjay Marathe beyond age 70, and Independent Director Mr. Bhanubhai Patel beyond age 75, all subject to shareholder approval at the 29th AGM on 24th September 2025.
The CFO exit without an immediate replacement could cause short-term uncertainty around financial reporting and controllership. The ESOP scheme and the Rs 5 crore increase in authorised capital point to future growth plans or possible fund-raising, which is mildly positive for long-term shareholders.